📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting the liver to treat the eye. (2023)

First Author: Seker Yilmaz B

Attributed to: Development of rAAV-mediated gene therapy for a severe paediatric metabolic liver disease: Ornithine Transcarbamylase deficiency. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202217285

PubMed Identifier: 36846970

Publication URI: http://europepmc.org/abstract/MED/36846970

Type: Journal Article/Review

Volume: 15

Parent Publication: EMBO molecular medicine

Issue: 4

ISSN: 1757-4676